Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment
Cancer Letters · 2023
DOI: 10.1016/j.canlet.2023.216397 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2023. Verfasst von Mengdan Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Nanoparticles. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 176 Literaturangaben. Gefördert von: Dalian University of Technology, Liaoning Cancer Hospital and Institute.
Abstract (Originalsprache)
Melanoma, the most aggressive form of cutaneous malignancy arising from melanocytes, is frequently characterized by metastasis. Despite considerable progress in melanoma therapies, patients with advanced-stage disease often have a poor prognosis due to the limited efficacy, off-target effects, and toxicity associated with conventional drugs. Nanotechnology has emerged as a promising approach to address these challenges with nanoparticles capable of delivering therapeutic agents specifically to the tumor microenvironment (TME). However, the clinical approval of nanomedicines for melanoma treatment remains limited, necessitating further research to develop nanoparticles with improved biocompatibility and precise targeting capabilities. This comprehensive review provides an overview of the current research on nano-drug delivery systems for melanoma treatment, focusing on liposomes, polymeric nanoparticles, and inorganic nanoparticles. It discusses the potential of these nanoparticles for targeted drug delivery, as well as their ability to enhance the efficacy of conventional drugs while minimizing toxicity. Furthermore, this review emphasizes the significance of interdisciplinary collaboration between researchers from various fields to advance the development of nanomedicines. Overall, this review serves as a valuable resource for researchers and clinicians interested in the potential of nano-drug delivery systems for melanoma treatment and offers insights into future directions for research in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.
- Second Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, China; The Liaon…
Förderung
- Dalian University of Technology
- Liaoning Cancer Hospital and Institute
Zitieren
APA
Xu, M., & Li, S. (2023). Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216397
Vancouver
Xu M, Li S. Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216397
BibTeX
@article{Xu2023,
author = {Xu, Mengdan and Li, Shenglong},
title = {Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment},
journal = {Cancer Letters},
year = {2023},
doi = {10.1016/j.canlet.2023.216397}
}
EUVIMED